Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Clinical Biochemistry|April 21, 2009
Prognostic significance of RASSF1A promoter methylation in operable breast cancerMagdalini Kioulafa, Loukas Kaklamanis, Dimitris Mavroudis, et al.
Gynecologic Oncology|January 12, 2010
Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: a meta-analysisAntonis Valachis, Nikolaos P Polyzos, Vassilis Georgoulias, et al.
Clinical Lung Cancer|July 28, 2006
A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancerDora Hatzidaki, Sofia Agelaki, Dimitris Mavroudis, et al.
Breast Cancer Research : BCR|September 30, 2008
Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patientsGalatea Kallergi, Sofia Agelaki, Antonia Kalykaki, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2010
Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effectMaria Spiliotaki, Haris Markomanolaki, Marilena Mela, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2014
Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinibAntonia Kalykaki, Sofia Agelaki, Galatea Kallergi, et al.
Critical Reviews in Oncology/Hematology|April 17, 2009
Fulvestrant in the treatment of advanced breast cancer: a systematic review and meta-analysis of randomized controlled trialsAntonis Valachis, Davide Mauri, Nikolaos P Polyzos, et al.
The Breast Journal|March 10, 2010
Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trialsAntonis Valachis, Davide Mauri, Nikolaos P Polyzos, et al.
Breast Cancer Research : BCR|June 14, 2011
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patientsGalatea Kallergi, Maria A Papadaki, Eleni Politaki, et al.
Molecular Cancer Therapeutics|November 8, 2018
Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast CancerMaria A Papadaki, Giannis Stoupis, Panayiotis A Theodoropoulos, et al.
Pageof 12